Analyst Reco. Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
37.51 ^USD	0.00%		+2.99%	+21.86%

04-29	Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER	CI
04-11	Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	02-26	MT
Truist Adjusts Price Target on Collegium Pharmaceutical to $40 From $37, Maintains Buy Rating	02-26	MT
Truist Adjusts Collegium Pharmaceutical's Price Target to $37 From $31, Keeps Buy Rating	01-04	MT
Jefferies Downgrades Collegium Pharmaceutical to Hold From Buy, Raises Price Target to $37 From $30	01-04	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $36 From $35, Maintains Buy Rating	25/08/23	MT
Jefferies Assumes Collegium Pharmaceutical at Buy With $30 Price Target	02/05/23	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $35 From $34, Maintains Buy Rating	05/01/23	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $34 From $36, Maintains Buy Rating	04/11/22	MT
HC Wainwright Downgrades Collegium Pharmaceutical to Neutral From Buy	08/08/22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $36 From $34, Keeps Buy Rating	06/04/22	MT
Piper Sandler Adjusts Collegium Pharmaceutical's Price Target to $42 From $36, Reiterates Overweight Rating	22/02/22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $34 From $28, Reiterates Buy Rating	15/02/22	MT
HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 From $26, Reiterates Buy Rating	15/02/22	MT
Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26	15/02/22	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rating	15/11/21	MT
HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating	05/11/21	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy Rating	05/11/21	MT
COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral from Overweight, Adjusts Price Target to $22 from $30	06/08/21	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating	06/08/21	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 from $31, Maintains Buy Rating	09/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Analyst Reco.

Filters